PAB 16.7% 0.7¢ patrys limited

Ann: Advances for Gastric Cancer Program , page-5

  1. 1,616 Posts.
    Presentation by Dan was good.
    Exciting stuff in the pipeline.

    But definitely a longer term investment in order to realize the full potential.
    Am happy to keep buying into this company for 2 reasons:
    - future of oncology will be around natural antibodies and non toxic forms of cancer treatment meaning great upside for PAB.
    - one day it might be me or someone I know that will rely on their technology.

    Expecting further alliances with pharma as trials progress.
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $13.37M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $7.864K 1.175M

Buyers (Bids)

No. Vol. Price($)
8 4361931 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1358675 5
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.